Feature Channels:

Personalized Medicine

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cancer, Cancer Research, Lung Cancer, thoracic cancer

Personalized Medicine, Proton Therapy and More Advances in Lung Cancer Research to Be Featured at Symposium Next Week

Thoracic2017logo_1.jpg

The press program for next week’s 2017 Multidisciplinary Thoracic Cancers Symposium features research advances in lung cancer including immunotherapy, proton therapy and liquid biopsy, among others.

Science

Channels:

Chagas’ disease , African Sleeping Sickness, Parasites, Trypanosome Parasites , tsetse fly

Bar-Ilan University Scientists Effectively Disrupt Communication Between Parasites That Spread Disease

A new intervention developed by Bar-Ilan University scientists to tamper with parasites' communication system may lead to the development of drugs to treat, and prevent the spread of, devastating diseases such as African sleeping sickness, leishmaniasis and Chagas' disease.

Medicine

Channels:

Multiple Myeloma

Mayo Clinic Researchers Identify Therapy That Shrinks Tumors in Patients with Multiple Myeloma

Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.

Science

Channels:

Acute Myeloid Leukemia, AML

New Drug Combination Targets Aggressive Blood Cancer

A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.

Medicine

Channels:

drug adverse events, Abacavir, Antiviral Drugs, HIV, abacavir hypersensitivity syndrome, Computer Modeling, HLA-B*57:01, Immune Response

Computer Models Could Allow Researchers to Better Understand, Predict Adverse Drug Reactions

abacavir-adverse-reaction.jpg

Computer model shows what happens at the molecular level during severe allergic reactions to abacavir, a common HIV drug

Medicine

Channels:

Study: Wireless Stimulation May Ease Migraine Pain as Well as Drugs

A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs. The study is published in the March 1, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Medicine

Channels:

Superbugs, Antibiotic Resistance, drug pipeline

Expert on Drug Discovery Available to Speak on the WHO List of Superbugs

kinch_350.jpeg

Medicine

Science

Channels:

New TB Drug Candidates Developed From Soil Bacteria

iStock_8256353_LARGE.jpg

A new treatment for tuberculosis (TB) is set to be developed using compounds derived from bacteria that live in soil - according an international collaboration of researchers, including the University of Warwick.

Medicine

Channels:

Endocrinology, Metabolic Diseases, Diabetes, Diabetes Care, Health Care Systems, Pharmacoeconomics, Health Economics

Collaborative Diabetes Clinic Lowers Health Care Costs

diabetes_infographic_hirsch_morello.jpg

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego are running a Diabetes Intensive Medical Management (DIMM) “tune up” clinic for complex type 2 diabetes patients. In a study published in the March 2017 issue of the Journal of Managed Care & Specialty Pharmacy, the researchers report the clinic’s economic benefits, which include an estimated cost avoidance of $5,287 per DIMM clinic patient over three years.

Medicine

Channels:

opioid abuse, Opioid, Epidemic, Chronic Pain, Patient-Centered Outcomes Research Institute

Cedars-Sinai to Study Most Effective Ways for Doctors to Discuss Opioid Use with Patients Suffering From Chronic Pain

Cedars-Sinai investigators are gearing up to study the most effective ways for doctors to discuss opioid use with chronic pain patients in an effort to reduce the impact of pain while curbing overuse of these addictive drugs. The research team has received $2 million from the Patient-Centered Outcomes Research Institute to conduct the study, which will launch in 2017.







Chat now!